Patent US5200312A successfully refreshed from Google Patents.
US5200312A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Membrane based dot immunoassay and method of use
Assignee: United States Department of the Navy
•
Filing: 1991-12-30
•
Granted: 1993-04-06
•
Expires: 2011-12-30
Abstract
Abstract Antigens or antibodies are detected using a novel membrane based immunoassay. Known antigens or antibodies which will form complexes with antigens/antibodies to be assayed are spot filtered with pressure through a membrane. The membrane, either by itself or attached to a base material as a test strip, is incubated with a test fluid. Consequently, the resulting antibody-antigen complex is incubated directly or after an intermediate anti-antibody incubation with enzyme conjugated immunoglobulin and exposed to substrate which produces a colored insoluble product if the test target is present.
Inventors
- 👤 John J. Oprandy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 12:33
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/544; G01N33/545; Y; Y10; Y10S; Y10S435/00; Y10S435/97; Y10S436/00; Y10S436/807; Y10S436/81
Claims Analysis
Total Claims: 14
Claim 1
Independent Claim
57 words
A test strip for use in an aqueous immunobinding assay made by the method comprising: filtering an aqueous solution containing a ligand selected from the group consisting of an antigen, antibody, and antigen-antibody complex, under positive pressure through a hydrophobic polyvinylidene difluoride (PVDF) membrane to form a clearly defined spot; immobilizing said ligand by drying said membrane.
Claim 2
Dependent Claim
57 words
A test strip for use in an aqueous immunobinding assay made by the method comprising: filtering an aqueous solution containing a ligand selected from the group consisting of an antigen, antibody, and antigen-antibody complex, under positive pressure through a hydrophobic polyvinylidene difluoride (PVDF) membrane to form a clearly defined spot; immobilizing said ligand by drying said membrane.
Claim 3
Dependent Claim
15 words
A test strip as described in claim 1 wherein the said ligand is an antigen.
Claim 4
Dependent Claim
15 words
A test strip as described in claim 1 wherein the said ligand is an antibody.
Claim 5
Dependent Claim
16 words
A test strip as described in claim 1 wherein the said ligand is an antigen-antibody complex.
Claim 6
Dependent Claim
16 words
A test strip as described in claim 2 wherein said antigen is eastern equine encephalomyelitis virus.
Claim 7
Dependent Claim
16 words
A test strip as described in claim 2 wherein said antigen is St. Louis encephalitis virus.
Claim 8
Dependent Claim
22 words
A test strip as described in claim 3 wherein said antibody is an IgG mouse monoclonal antibody to meningococcal group A polysaccharide.
Claim 9
Independent Claim
56 words
A method for making a test strip for use in an aqueous immunobinding assay comprising: filtering an aqueous solution containing a ligand selected from the group consisting of an antigen, antibody, and antigen-antibody complex, under positive pressure through a hydrophobid PVDF membrane to form a clearly defined spot; and immobilizing said ligand by drying said membrane.
Claim 10
Independent Claim
56 words
A method for making a test strip for use in an aqueous immunobinding assay comprising: filtering an aqueous solution containing a ligand selected from the group consisting of an antigen, antibody, and antigen-antibody complex, under positive pressure through a hydrophobid PVDF membrane to form a clearly defined spot; and immobilizing said ligand by drying said membrane.
Claim 11
Dependent Claim
195 words
An aqueous immunobinding assay method for detecting an antigen or antibody target in a test solution comprising: filtering an aqueous solution containing a ligand which specifically binds to said target wherein said ligand is selected from the group consisting of an antigen, antibody, and antigen-antibody complex, under positive pressure through a hydrophobic PVDF membrane to form a clearly defined spot; p1 immobilizing said ligand by drying said membrane to form a test strip; incubating said test strip in a blocking/wetting solution comprising a blocking agent in a wetting solution, wherein the amount of said blocking agent is sufficient to block all non-specific binding sites and said wetting solution comprises a surfactant in a buffer, wherein the amount of said surfactant is sufficient to reduce the hydrophobicity of said clearly defined spot; diluting said test solution in said wetting solution and incubating said test strip therein for a time sufficient for any target present to bind to said ligand and form a reacted test strip; incubating said reacted test strip with a label conjugated to an antigen or antibody which specifically binds to said target; and measuring said label to determine if said target is present.
Claim 12
Dependent Claim
195 words
An aqueous immunobinding assay method for detecting an antigen or antibody target in a test solution comprising: filtering an aqueous solution containing a ligand which specifically binds to said target wherein said ligand is selected from the group consisting of an antigen, antibody, and antigen-antibody complex, under positive pressure through a hydrophobic PVDF membrane to form a clearly defined spot; p1 immobilizing said ligand by drying said membrane to form a test strip; incubating said test strip in a blocking/wetting solution comprising a blocking agent in a wetting solution, wherein the amount of said blocking agent is sufficient to block all non-specific binding sites and said wetting solution comprises a surfactant in a buffer, wherein the amount of said surfactant is sufficient to reduce the hydrophobicity of said clearly defined spot; diluting said test solution in said wetting solution and incubating said test strip therein for a time sufficient for any target present to bind to said ligand and form a reacted test strip; incubating said reacted test strip with a label conjugated to an antigen or antibody which specifically binds to said target; and measuring said label to determine if said target is present.
Claim 13
Dependent Claim
34 words
The method according to claim 9 wherein said label is conjugated to an antibody and said label is selected from the group consisting of horseradish peroxidase, urease, alkaline phosphatase, glucose oxidase, and fluorescent molecules.
Claim 14
Dependent Claim
26 words
The method according to claim 10 wherein said label is horseradish peroxidase and its substrate is selected from the group consisting of 4chloro-1-naphthol and tetramethyl benzidine.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-04-05 | 1996-10-05 | 1997-04-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-04-05 | 2000-10-05 | 2001-04-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-04-05 | 2004-10-05 | 2005-04-06 | $7700.00 | Window Closed / Lapsed |